United States (US) GLP 1 Receptor Agonist Market (2025-2031) | Trends, Industry, Share, Competitive Landscape, Forecast, Companies, Value, Analysis, Outlook, Segmentation, Size & Revenue, Growth

Market Forecast By Product (Ozempic, Trulicity, Mounjaro, Wegovy, Rybelsus, Saxenda), By Application (Type 2 Diabetes Mellitus, Obesity), By Route of Administration (Parenteral, Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) And Competitive Landscape
Product Code: ETC9966625 Publication Date: Sep 2024 Updated Date: Jan 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) GLP 1 Receptor Agonist Market Outlook
  • Market Size of United States (US) GLP 1 Receptor Agonist Market, 2024
  • Forecast of United States (US) GLP 1 Receptor Agonist Market, 2031
  • Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Revenues & Volume for the Period 2021- 2031
  • United States (US) GLP 1 Receptor Agonist Market Trend Evolution
  • United States (US) GLP 1 Receptor Agonist Market Drivers and Challenges
  • United States (US) GLP 1 Receptor Agonist Price Trends
  • United States (US) GLP 1 Receptor Agonist Porter's Five Forces
  • United States (US) GLP 1 Receptor Agonist Industry Life Cycle
  • Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Product for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Ozempic for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Trulicity for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Mounjaro for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Wegovy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Rybelsus for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Saxenda for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Application for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Type 2 Diabetes Mellitus for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Obesity for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Route of Administration for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Parenteral for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Oral for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Hospital Pharmacies for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Retail Pharmacies for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) GLP 1 Receptor Agonist Market Revenues & Volume By Online Pharmacies for the Period 2021- 2031
  • United States (US) GLP 1 Receptor Agonist Import Export Trade Statistics
  • Market Opportunity Assessment By Product
  • Market Opportunity Assessment By Application
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By Distribution Channel
  • United States (US) GLP 1 Receptor Agonist Top Companies Market Share
  • United States (US) GLP 1 Receptor Agonist Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) GLP 1 Receptor Agonist Company Profiles
  • United States (US) GLP 1 Receptor Agonist Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) GLP 1 Receptor Agonist Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) GLP 1 Receptor Agonist Market - Industry Life Cycle

3.4 United States (US) GLP 1 Receptor Agonist Market - Porter's Five Forces

3.5 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume Share, By Product, 2021 & 2031F

3.6 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 United States (US) GLP 1 Receptor Agonist Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 United States (US) GLP 1 Receptor Agonist Market Trends

6 United States (US) GLP 1 Receptor Agonist Market, By Types

6.1 United States (US) GLP 1 Receptor Agonist Market, By Product

6.1.1 Overview and Analysis

6.1.2 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Product, 2021- 2031F

6.1.3 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Ozempic, 2021- 2031F

6.1.4 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Trulicity, 2021- 2031F

6.1.5 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Mounjaro, 2021- 2031F

6.1.6 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Wegovy, 2021- 2031F

6.1.7 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Rybelsus, 2021- 2031F

6.1.8 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Saxenda, 2021- 2031F

6.2 United States (US) GLP 1 Receptor Agonist Market, By Application

6.2.1 Overview and Analysis

6.2.2 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Type 2 Diabetes Mellitus, 2021- 2031F

6.2.3 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Obesity, 2021- 2031F

6.3 United States (US) GLP 1 Receptor Agonist Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Parenteral, 2021- 2031F

6.3.3 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Oral, 2021- 2031F

6.4 United States (US) GLP 1 Receptor Agonist Market, By Distribution Channel

6.4.1 Overview and Analysis

6.4.2 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.4.3 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.4.4 United States (US) GLP 1 Receptor Agonist Market Revenues & Volume, By Online Pharmacies, 2021- 2031F

7 United States (US) GLP 1 Receptor Agonist Market Import-Export Trade Statistics

7.1 United States (US) GLP 1 Receptor Agonist Market Export to Major Countries

7.2 United States (US) GLP 1 Receptor Agonist Market Imports from Major Countries

8 United States (US) GLP 1 Receptor Agonist Market Key Performance Indicators

9 United States (US) GLP 1 Receptor Agonist Market - Opportunity Assessment

9.1 United States (US) GLP 1 Receptor Agonist Market Opportunity Assessment, By Product, 2021 & 2031F

9.2 United States (US) GLP 1 Receptor Agonist Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 United States (US) GLP 1 Receptor Agonist Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 United States (US) GLP 1 Receptor Agonist Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 United States (US) GLP 1 Receptor Agonist Market - Competitive Landscape

10.1 United States (US) GLP 1 Receptor Agonist Market Revenue Share, By Companies, 2024

10.2 United States (US) GLP 1 Receptor Agonist Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All